Summit

SOUTH DAKOTA BIOTECH BOARD PRESIDENT

South Dakota Biotech President Mel Ustad will give highlights of the association in the past year and provide an overview of relevant issues and progress at the state and national levels.  

Dr. Melvin Ustad, Director of South Dakota EPSCoR, coordinating South Dakota EPSCoR activities and serving as the Project Director of the National Science Foundation EPSCoR Research Infrastructure Improvement Track 1 project.  The five year $24 million project involves the six regental institutions, three tribal colleges, two private colleges. Dr. Ustad served as the Director of Commercialization, in the Governor’s Office of Economic Development for Governor Rounds and Daugaard. Dr. Ustad has extensive experience leading collaborative interdisciplinary public / private research and economic development projects. Dr. Ustad previously served as Acting and Interim Vice President for Research at the University of South Dakota, Director of the South Dakota SBIR Center, and worked for Senator Larry Pressler in Washington, DC. He has also served or is currently serving on the Board of Directors of numerous national and state technology entrepreneurship organizations. Dr. Ustad has been an active researcher throughout his career, serving as principal investigator on numerous research and outreach projects supported by various federal agencies and private foundations.

LEARN MORE

Dusty Johnson brings an energetic and optimistic style to Washington as South Dakota’s lone voice in the U.S. House of Representatives. A recognized leader in issues related to rural America, agriculture, and welfare reform, he serves on the Agriculture Committee and as Chairman of the Commodity Markets, Digital Assets, and Rural Development Subcommittee. As a member of the Transportation & Infrastructure Committee, Dusty has been focused on finding solutions to the supply chain crisis through his Ocean Shipping Reform Act which passed the House in 2021. Appointed to the Select Committee on China, Dusty addresses the 360-degree threat posed by China, especially their ownership of American ag land and ag businesses and control over tech. Prior to being elected to Congress, he served as chief of staff to the Governor and as vice president of an engineering firm specializing in rural telecommunications. Dusty lives in Mitchell with his wife and three sons.

LEARN MORE

 

Representative Tony Venhuizen, District: 13 Counties: Lincoln, Minnehaha - 2024

Tonnis H. Venhuizen is an Armour native. He is a graduate of South Dakota State University, where he earned his B.S. in history and political science, and the University of South Dakota School of Law, where he was an editor of the South Dakota Law Review. In 2021, Governor Kristi Noem appointed Venhuizen to the South Dakota Board of Regents; he had previously been appointed to the Board by Governor Mike Rounds, serving from 2003-08.

Venhuizen managed the successful gubernatorial campaign of Dennis Daugaard in 2010. He worked in the governor’s office throughout the Daugaard administration, including as chief of staff from 2014-19. Venhuizen stayed on in the administration of Governor Noem as a senior advisor in 2019, and then returned as chief of staff in 2020-21. Prior to that, Venhuizen worked on Mike Rounds’ successful gubernatorial campaigns in 2002 and 2006.  Venhuizen also served with the Janklow-Rounds gubernatorial transition in 2002, the Rounds-Daugaard transition in 2010, and the Daugaard-Noem transition in 2018.

Venhuizen serves on the board of directors of the Trail of Governors Foundation, which is erecting life-size bronze statues of every former South Dakota governor throughout the capital city of Pierre. He has encouraged the placement of South Dakota State Historical Society markers to commemorate the lives of former governors, leading to the placement of ten new markers.  

In 2012, Venhuizen led the effort to pass legislation, codified at SDCL § 1-27-1.19 to 1-27-1.22, that preserves the papers of former governors and ensures that all papers eventually become available for historical research. In 2018, he advocated for the designation of Peter Norbeck’s birthday, August 27, as a state working holiday.  enhuizen coordinated the commissioning of a bust of George S. Mickelson, which was placed in the lobby of the State House of Representatives to commemorate the 25th anniversary of Mickelson’s death. While in the governor’s office, Venhuizen was particularly honored to help coordinate the State Capitol memorial services for former governors William J. Janklow and Walter Dale Miller.

Luke Lindberg is the President & CEO of South Dakota Trade, a 501c(6) public-private-partnership that navigates international trade for South Dakota.

Previously, Mr. Lindberg served as the Chief of Staff and Chief Strategy Officer at the Export-Import Bank of the United States. As the agency’s second-highest ranking official, he was responsible for managing the day-to-day operations of EXIM and advancing strategic initiatives such as the program on “China and Transformational Exports”, opening new markets for American Liquified Natural Gas, securing America’s supply of Critical Minerals & Rare Earths, and protecting allies in the race to deploy 5G globally. He also led EXIM’s involvement in the execution of the ground-breaking Abraham Accords. Mr. Lindberg earned the Distinguished Service Award, which recognizes distinctive accomplishment and leadership that significantly benefit EXIM and the nation.

Today, Mr. Lindberg Serves on the board of directors of the National Association of District Export Councils, and the Children’s Home Society. He holds advisory roles with the U.S. Global Leadership Coalition, the Krach Institute for Tech Diplomacy at Purdue University, and is a member of the Council on Foreign Relations. Additionally, Mr. Lindberg is a Senior Fellow at the America First Policy Institute and has been featured by Fox News, The Washington Times, The Hill, The Daily Caller, The Federalist, and The Farm Journal, for his ‘Thought Leadership’ on international affairs and agriculture policy. Mr. Lindberg earned a Master of Business Administration, a Master of Public Policy, and a Bachelor of Arts in Government & Politics, all from the University of Maryland.

ABOUT SOUTH DAKOTA TRADE
South Dakota Trade navigates international trade for South Dakota. The association — a 501c(6) public-private partnership — administers South Dakota’s STEP Grant program, conducts export education, facilitates trade missions, and offers free and confidential consulting services to South Dakotan companies.

LEARN MORE
 

Joe Beck, Executive Director of Corporate Development, Viaflex
 

Joe Beck has a diverse work experience in various roles and positions. Joe started their career as a Facilities Engineering Technician at the U.S. Geological Survey in 2011. Joe then moved on to Raven Industries where they worked as a Facilities and Corporate Services employee and later as a Plant Engineer. In 2015, Joe joined Raven Aerostar as a Program Manager and was later promoted to the position of Plant Manager. Joe then transitioned to Raven Engineered Films in 2019, serving as a Business Director. Currently, Joe is working as the Executive Director of Corporate Development at Viaflex since April 2022.

Joe Beck earned a Bachelor of Science (B.S.) in Mechanical Engineering from South Dakota State University in the years 2011 to 2014. Joe then pursued a Master of Business Administration (M.B.A.) with a focus on Business Administration, Management, and Operations at UNC Kenan-Flagler Business School from 2015 to 2017. Joe also pursued additional certifications in Mergers and Acquisitions from Columbia Business School. Joe holds the certification as an Engineer in Training from the South Dakota Board of Regents.

ABOUT VIAFLEX
Dedicated to protecting the Earth while promoting industry.

We have been supplying high-quality flexible films, covers and lining to major markets in the US and throughout the world. While our products are sold internationally, our supply chain is not. We are a made-in-America outfit dedicated to providing our clients with custom-made solutions and services for even the most challenging environmental projects.

LEARN MORE

Dr. Joseph P. Cassady is the South Dakota Corn Endowed Dean of the SDSU College of Agriculture, Food and Environmental Sciences. He was SDSU Animal Science Department Head from 2013 until being appointed Dean in 2022, and concurrently Interim Dairy and Food Science Department Head from 2020 to 2022. He spent 12 years on the North Carolina State University faculty. Dr. Cassady has maintained a key focus on increasing research productivity and doubled graduate student enrollment in the Dept. of Animal Science. He provides oversight of operations and budgets for six livestock units, a meat teaching/research laboratory, a feed mill and nutrition, physiology and genetics research laboratories. He also provided strategic direction for the SDSU Rodeo Team, and livestock, meats, & wool judging teams. Dr. Cassady’s leadership and rapport with stakeholders helped raise over $14 million, to complete both a $7.4 million Swine Education and Research Facility and $6 million Cow-Calf Education and Research Facility.

LEARN MORE

Dennis Harstad, VP of Operations/General Manager, Houdek


ABOUT HOUDEK
Like the soil from which we're named, we are a diverse mixture, comprised of scientists, technicians, innovators, and stewards putting our life's work into bringing fermentation technology to the world's food needs.

We provide the aquaculture, pet nutrition, and human health markets with sustainable, traceable, and highly valuable food ingredients... and if you have three minutes, you can experience our work via the most important aspect of our work - our people.

LEARN MORE

Scott D. Marty, Ph.D., an Intellectual Property Partner in Ballard Spahr’s Atlanta office, has been recognized as the Patent Strategy Attorney of the Year – South at the LMG Life Sciences Awards Americas 2022.

Now in its 10th year, The LMG Life Sciences Awards Americas 2022 aims to highlight the best legal practitioners via a thorough survey of the life sciences sector. Practitioners and teams across the United States and Canada are represented in categories including regulatory, corporate, intellectual property, and litigation.

Dr. Marty co-leads Ballard Spahr’s Life Sciences Industry Group. His clients range from multinational Fortune 500 companies to emerging growth start-ups and benefit from his experience in navigating all areas of drug discovery through development, including product launch. In the start-up space, he provides strategic patent counseling to life sciences companies, guiding them through every stage of a product's life cycle.

ABOUT BALLARD SPAHR
Ballard Goes Beyond

We provide strategic legal services and business solutions of the highest quality, delivered with uncommon efficiency.

With more than 600 lawyers in 15 U.S. offices, we bring industry knowledge augmented by tenacity, initiative, and a drive for results—creating an outsized advantage for clients in litigation, transactions, and regulatory compliance.

LEARN MORE
 

Alan Young, Ph.D., Chief Technology Officer (CTO) and Founder, Medgene Labs

Dr. Young’s career has focused on the application of domestic animal models to biomedical applications. Dr. Young received his BSc and PhD in Immunology from the University of Toronto, focusing on the role of the migratory immune system in defense against disease. Following postdoctoral training in lymphatic physiology, Dr. Young took a position as Scientific Member of the Ruminant Immunology Laboratory at the Basel Institute for Immunology. Following closure of the Institute, Dr. Young accepted a faculty position in the Department of Surgery at Harvard Medical School, prior to moving to his current position at the Department of Veterinary and Biomedical Sciences at South Dakota State University. Dr. Young has served as the lead on academic initiatives designed to promote cross-institutional and academic-industry collaborations, including founding the Multistate Research Committee to deal with BSE in the United States and as a Co-PI for development of a Rift Valley Fever vaccine through the Center of Emerging Zoonoses and Animal Diseases at Kansas State University. His training as an Immunologist focuses much of his work on the response of domestic animals to emerging and zoonotic diseases, and the application of animal models to development of new therapies, diagnostics, and research models for human disease. Since 2004, Dr. Young has been an active participant in translational technology development, authoring and supervising several successful Phase I and Phase II SBIR projects in collaboration with Federal Laboratories and Academic Institutions within the United States and Canada. In 2011, Dr. Young founded VST/Medgene Labs to assist in the translation of early stage technologies to the marketplace and to develop new vaccine and diagnostic tools for human and veterinary medicine. Medgene Labs is a USDA-licensed firm for production of both Autogenous and Prescription-Platform vaccines, with commercial products providing solutions for swine and cattle, with additional products serving the needs of minor species such as deer, rabbits, and bison. In addition to these commercially relevant products, Medgene’s platform is also being applied towards solutions for Foreign Animal Diseases, including Rift Valley Fever, Classical Swine Fever, Nipah Virus, and Highly Pathogenic Avian Influenza.

ABOUT MEDGENE LABS
Medgene is an animal health company focused on providing Prescription Platform vaccines to veterinarians and producers. Medgene serves both livestock and companion-animal practices. Medgene’s Prescription Platform system ensures that all the ingredients that go into our vaccines are animal origin free.

LEARN MORE

A graduate of the University of Manitoba, Mr. Rob Patterson holds degrees in both biology and nutritional biochemistry and has a specific interest and focus on applied swine and poultry nutrition. As the Vice President of Innovation & Commercialization for CBS Bio Platforms, Mr. Patterson is responsible for all aspects of technology commercialization including Research and Development, Regulatory and Quality Systems, Sales & Marketing, and Business Development activities. 

Rob has authored and co-author several papers focused on advancing the application of various feed additive technologies in swine and poultry diets. Additionally, Rob has been invited to speak at scientific and industry conferences around the world. He is also the past chair of the Nutrition Council, which serves as the technical liaison to the Animal Nutrition Association of Canada, the national lobbying group for the Canadian Feed Industry.

ABOUT CBS BIO PLATFORMS
CBS Bio Platforms Inc. is an innovation-driven company committed to advancing feed technology and animal nutrition. With over 40 years of experience, CBS has developed a broad portfolio of natural feed supplements, enzymes, and yeast-based technologies designed to enhance animal performance, improve intestinal tract health, and support efficient disease management operations.

Our global footprint includes facilities in Canada, international markets throughout Asia and South America and now in the United States with our first production facility opening in Volga, SD. With strategic university partnerships and a robust research and development framework, CBS Bio Platforms continues to pioneer solutions that meet the evolving needs of nutritionists, veterinarians, farmers, and commercial producers.

LEARN MORE

Doug Berven, Vice President of Corporate Affairs, POET

Doug Berven joined POET in March 2003 and has served the organization in several key roles since then. In his current role as Vice President of Corporate Affairs, Berven promotes the corporate objectives of POET, the importance of agriculture, and the benefits of biofuels domestically and internationally.

Berven currently sits on BIO’s Industrial and Environmental Section Governing Board, the U.S. Grains Council Ethanol Advisory Team, the U.S. Farmers and Ranchers Alliance Executive Committee and Board, South Dakota Agriculture Foundation Board, is a Senior Advisor to Solutions From the Land, is an Emeritus Board Member of the American Council on Renewable Energy, is the Executive Director of the South Dakota Ethanol Producers Association, and serves on several other industry associated work groups, committees and associations. He has also served on several of POET’s plant Boards of Directors. Berven also manages strategic corporate relations for POET, promotes state, national and international policy objectives for the industry, and is a recognized authority on biofuels, renewable energy and agriculture.

Prior to joining POET, Berven held various roles in banking, real estate development and medical business consulting. Berven received his Bachelor of Science degree in Business Administration from Augustana College in Sioux Falls, S.D., where he currently resides with his wife and two children.

ABOUT POET
Founded in 1987, we have grown from a single, humble bioprocessing facility in Scotland, South Dakota to the world’s largest producer of biofuel and a global leader in sustainable bioproducts. Today we are headquartered in Sioux Falls, South Dakota, with 34 bioprocessing facilities across the midwest and nearly 2,400 team members. Our integrated business model combines research and development with expertise in design and construction, technology, operations, public affairs, and marketing.

The same spirit of ingenuity that helped us to pioneer an industry is alive and well today. POET nurtures an unceasing commitment to innovating powerful, practical solutions to some of the world’s most pressing challenges. Our world-class team of researchers and engineers works to unleash the regenerative power of agriculture by creating plant-based alternatives to petrochemicals, like bioethanol, distillers grains, corn fermented protein, distillers corn oil, biogenic CO2 and dry ice, purified alcohol, and asphalt rejuvenator. Today, POET holds more than 80 patents worldwide and continues to break new ground in biotechnology, yielding ever-cleaner and more efficient renewable products and energy.

While the size of our business and scope of our vision have evolved, we remain focused on reducing our dependence on fossil-based products, revitalizing global agriculture, and creating a brighter world for generations to come.

LEARN MORE

William S. Harris, Ph.D., FAHA – President and CEO, OmegaQuant

Dr. Harris is an internationally recognized expert on omega-3 fatty acids and how they can benefit patients with heart disease. He obtained his Ph.D. in Human Nutrition from the University of Minnesota and did post-doctoral fellowships in Clinical Nutrition and Lipid Metabolism with Dr. Bill Connor at the Oregon Health Sciences University.

His interest in omega-3 fatty acids began with his postdoctoral work when he published his first study on the effects of salmon oil on serum lipids in humans (1980). Since that time he has been the recipient of five NIH grants for studies on the effects of omega-3 fatty acids (EPA and DHA) on human health. He has more than 300 publications relating to fatty acids, including omega-3s, in medical literature and was an author on two American Heart Association scientific statements on fatty acids: “Fish Consumption, Fish Oil, Omega-3 Fatty Acids and Cardiovascular Disease” (2002), and “Omega-6 Fatty Acids and Risk for Cardiovascular Disease” (2009) both published in the journal Circulation.

Dr. Harris is a Professor in the Department of Medicine in the Sanford School of Medicine at the University of South Dakota and the President and CEO of OmegaQuant.

ABOUT OMEGAQUANT
OmegaQuant is an independent, CLIA-certified lab that offers Omega-3 Index, Prenatal DHA and Mother’s Milk DHA testing to researchers, clinicians and the public.

We perform fatty acid analysis in Sioux Falls, SD, for commercial and academic research collaborators, and for consumers interested in monitoring their nutritional status in both blood and breast milk.

Our goal is to offer the highest quality fatty acid analytical services to researchers and to provide simple tests of nutritional status to consumers, with the ultimate purpose of advancing the science and use of nutrients to improve health.

LEARN MORE
 

Erik Ehli, Ph.D., Research Scientist, Avera Genetics

Currently working as a Research Scientist at Avera Genetics, Dr. Ehli has a research interest in the molecular genetics of complex diseases. He is actively involved in leading genotyping projects on samples collected from children and adolescents through the Netherlands Twin Register.

In addition, Dr. Ehli is working on the molecular characterization of metastatic breast cancer and has an interest in understanding the tumor genetics of gynecological cancer, specifically uterine sarcoma.

Dr. Ehli has extensive training in a diverse range of molecular genetics techniques, including high density SNP genotyping, methylation, next generation sequencing, and pharmacogenetic profiling.

ABOUT AVERA GENETICS
Avera Genetics has been forward-looking since opening its doors in 2006. This strong history of excellence has brought us to lead the way with a large twin registry bank — the first and only in South Dakota — and precision medicine breakthroughs.

As a human molecular genetics laboratory, we have the capability to undertake a wide range of clinical and research projects using advanced technology including:

• Behavioral and cancer genetic studies

• Biobanking

• Personalized medicine

• Tumor registries

• Twin research

By advancing science through numerous partnerships and collaborations — both nationally and internationally — Avera Genetics is already improving the care provided to Avera patients and communities while continuing to advance science and medicine.

LEARN MORE
 

Alexandra Kropotova, EVP & Chief Medical Officer, SAB BIO

Dr. Kropotova MD, MBA is our Executive Vice President & Chief Medical Officer, joining SAB in June, 2022 to lead the strategy, direction, and execution of the company’s clinical development for the entire portfolio. Dr. Kropotova is a biopharmaceutical executive with expertise in all phases of global clinical development, translational medicine and medical affairs. Prior to joining SAb Biotherapeutics, as a Therapeutic Area Head of Global Specialty R&D at Teva Pharmaceuticals, Alexandra led innovative drug development focused on delivering a broad portfolio of immunology, respiratory, and immuno-oncology assets spanning from pre-IND to BLA/NDA filing of biologics and complex drug-device combination products. Prior to Teva, Dr. Kropotova served in various roles at Sanofi, including Vice President, Strategy & Strategic Planning Head, North American Medical Affairs; Associate Vice President and subsequently Vice President, Immuno-Inflammation, Global R&D Clinical Development; and Senior Medical Director, Respiratory, Allergy & Anti-Infectives. She also served in various roles at Pfizer Inc., most recently as Director & Head of Global Clinical Respiratory and Analgesics. She continues to serve on the Board of Directors at iBio, a global leader in plant-based biologics manufacturing and development of novel biopharmaceuticals. Dr. Kropotova received her MBA from Ohio University Graduate School of Business, Athens, Ohio; and her M.D. in Internal Medicine from the Vladivostok State Medical University, Vladivostok, Russia.

ABOUT SAB
SAB BIO is a clinical-stage biopharmaceutical company working to treat and prevent immune and autoimmune disorders. Founded in 2014 and traded on NASDAQ (SABS) since 2021, SAB BIO’s innovative genetic engineering platform produces human, multi-targeted, high-potency immunoglobulins (IgGs), without the need for human donors or convalescent plasma. The science behind the platform originated in 1998, and the company began its first clinical trials in 2017.  

To date, SAB BIO has conducted seven clinical trials that have dosed 700 individuals across multiple therapeutic areas. The safety and immunogenicity database for these trials shows zero patients with serum sickness or neutralizing anti-drug antibodies, which suggests an improved safety profile over other therapies. 

The company’s lead investigational candidate, SAB-142, is a novel, potentially disease-modifying therapy for type 1 diabetes (T1D). As a potentially redosable human antibody, rather than an insulin or chronic therapy, SAB-142 is being investigated for its ability to delay clinical onset and progression of T1D. 

LEARN MORE
 

Karoliina Slack, Vice President - Sanford World Clinics at Sanford Health

Karoliina Slack has extensive experience in healthcare operations and marketing, with a focus on improving quality and efficiency. Karoliina has held various leadership roles in companies such as Sanford Health, OmniHealth, and Good Samaritan Society. Karoliina has a strong educational background in Business Administration and Marketing, holding both a Bachelor's and Master's degree in these fields. Karoliina is currently the Vice President at Sanford Health, leading the transformation of healthcare operations and collaborating with stakeholders to improve population health worldwide.

ABOUT SANFORD WORLD CLINIC
Sanford Health started the Sanford World Clinic initiative in 2007 to provide permanent health care services for children.

Sanford World Clinic is always expanding its scope of services to meet the unique needs of the areas we serve. Broader primary care services, regenerative medicine, specialized procedures, weight loss programs, diabetes research and clinic education are just a few of the specializations developed to serve populations around the world.

Models implemented at each location are customized to meet the specific needs and opportunities presented in the market.

LEARN MORE

Sophie Alcorn, Alcorn Founding Attorney & Certified Specialist - Immigration

As the founder and CEO of Alcorn Immigration Law, I help tech startups and their founders obtain visas and green cards to live and work legally in the United States. A second-generation immigration attorney, I am also a Certified Specialist in Immigration and Nationality Law, a rare accreditation from the State of California Board of Legal Specialization.

I author TechCrunch's Ask Sophie™ weekly immigration column, where I answer questions and share insights on U.S. immigration for tech entrepreneurs and professionals. My mission is to empower the world's best and brightest tech talent to pursue their dreams in the U.S. and to drive innovation and economic growth. I am passionate about AI, ML, biotech, space tech and robotics, and I regularly work with Sequoia, a16z, and YC-backed startups in these fields.

ABOUT ALCORN
The Alcorn Advantage Business & Individual Immigration

People from around the world have chosen Alcorn for their U.S. Immigration needs because of our proven ability to build positive relationships with clients—and win. We bring compassion, active listening, and attention to detail to every interaction and put our hearts into building your dreams.

Our mission is to overcome borders, expand opportunity, and connect the world by practicing compassionate, visionary, and rigorous immigration law in service of the betterment of humanity. We are proud of our efforts and the 95%+ approval rating we have earned.

LEARN MORE

Dan Engebretson, Ph.D., Vice President for Research & Sponsored Programs, University of South Dakota

Dan Engebretson earned his Ph.D. in Physical Chemistry in 1997 from Michigan State University in East Lansing, MI under the direction of Drs. Daniel Nocera and George Leroi. After graduate school he took the position of Senior Scientist at Dakota Technologies, Inc. in Fargo, ND. He then accepted the position of Senior Research Specialist at the Avera Research Institute in Sioux Falls, SD. After Avera he joined The University of South Dakota as the Director of the Center for Research and Development of Light-Activated Materials, a position he still holds in addition to his duties as the Chair of Biomedical Engineering and the Director of the Graduate Education and Applied Research Center.

Dr. Engebretson's major research interests are the development Fluorescence Resonance Energy Transfer (FRET)-based sensors for in vitro diagnostics and targeted drug delivery. His research has been funded by the National Science Foundation, National Institutes of Health, Department of Defense, and the Department of Transportation.

ABOUT UNIVERSITY OF SOUTH DAKOTA
The University of South Dakota is a vibrant setting of innovation artistry and discovery, with research and creative activity opportunities in all disciplines across campus. USD researchers collaborate with industry professionals to bring new technologies to market as well as carrying out fundamental research in order to elucidate physical processes, improve human health, and protect the environment. In addition to individual research, the university hosts multi-disciplinary competitive research centers that foster academic excellence and spur economic growth. Biomedical engineering, chemistry, and physics are the main pillars of USD’s materials research; key research strengths and facilities within this area include the Center for Ultra-low Background Experiments in Dakotas (CUBED), Graduate Education and Applied Research Center (GEAR), and Center for Security Printing and Anti-Counterfeiting Technologies (SPACT). USD is also home to the state's only medical school. Sanford School of Medicine faculty members teach students the latest techniques and skills for a career in biomedical research. Critical biomedical research areas include anatomy and structural biology, cancer biology, immunology, cardiovascular sciences, microbiology, neuroscience, rural healthcare, pharmacology and physiology, among others. Key research groups and facilities include: South Dakota Biomedical Research Infrastructure Network (BRIN), Neuroscience & Nanotechnology Network (USD-N3), Center for Brain & Behavior Research (CBBRe) and USD’s two biomedical cores: Behavioral Core and Physiology Core.

LEARN MORE

Co-Founder and General Partner, South Dakota First Capital
South Dakota Biotech Board Vice President

Dr. Mark Stowers is the Biotech Executive of The Global Bluefish Company, LLC, a global management and financial advisory company which focuses on de-risking agriculture, food, bioproducts, and bioenergy and chemical businesses globally.  It provides diverse business and technical guidance encompassing research management, product development, business development, marketing, mergers and acquisitions, licensing, corporate finance and general management. 

Mark was most recently Chief Operations Officer and President of North America at Inari Agriculture, an emerging gene editing and computational seed design company targeting improved yield and resiliency of corn, soybean and wheat. While at Inari, he was responsible for the early-stage set-up of the company, its product development, the development and launch of the company’s “go to market” strategy, information technology, and its seed supply chain.

Previously he held senior executive positions in the research and business development areas at Limagrain, POET and Monsanto (now Bayer Crop Science). He has also worked to commercialize new biotechnologies and helped new business start-ups as President and CEO of MBI International and the Bio-Business Incubator of Michigan.  He was the co-founder of Draths Corporation and the UCDavis-HM.Clause Life Sciences Innovation Center.  Over the last twenty-five years he led/supported equity and debt financings of over $2 billion including a $200+ million IPO.

Dr. Stowers holds a Ph.D. in microbiology from North Carolina State University (1982) and completed post-doctoral studies at the Boyce Thompson Institute at Cornell University (1983).  He is a NC State University College of Agriculture and Life Sciences Distinguished Alumnus (2003). He (as the principal from HM.Clause) is the recipient of the UC Davis Chancellor’s award Innovative Community Partner award (2016). He has served on numerous company, not-for-profit, and university boards and advisory committees.

South Dakota Trade Mission: Connecting South Dakota Companies with East Asia  
Biotech's collaborative 2024 trade mission is fostering valuable connections between South Dakota businesses and East Asian markets, creating new opportunities for growth and collaboration.

MODERATOR: Luke Lindberg, President & CEO - South Dakota Trade
SPEAKERS: 
Dennis Harstad, Houdek - General Manager
Joe Cassady, Dean, College of Ag, SDSU

South Dakota Trade navigates international trade for South Dakota. The association — a 501c(6) public-private partnership — administers South Dakota’s STEP Grant program, conducts export education, facilitates trade missions, and offers free and confidential consulting services to South Dakotan companies.

South Dakota International Trade Statistics

• Total exports: $6.7 billion

• Agricultural exports: $4.92 billion

• Manufacturing exports: $1.73 billion

• 27,075 jobs supported by exports
   

LEARN MORE



 

Sowing Innovation: South Dakota’s Global Impact on Agricultural and Environmental Biotechnology  

MODERATOR:
SPEAKERS: 
Rob Patterson, CEO - CBS Bio Platforms
Doug Berven, Vice President of Corporate Affairs - POET

Connecting Care: Global Healthcare Partnerships from South Dakota Touching Lives Worldwide
Learn about how international collaborations are enhancing healthcare innovation and delivery within South Dakota, positioning the state as a key player in global health.

MODERATOR:
SPEAKERS:
Sanford Research Clinical Trials or Sanford World Clinics
Erik Ehli, Ph.D, Research Scientist, Avera Clinical Trials/International Twin Registry
Alexandra Kropotrova, MD, MBA, EVP & Chief Medical Officer, SAB Biotherapeutics

Engaging an International Student Workforce. Discover the impact of integrating international students into South Dakota's biotech sector and how it's contributing to a diverse and innovative workforce.

MODERATOR: Dan Engebretson, Ph.D., University of South Dakota, South Dakota Biotech Board Member
SPEAKERS:
Sophie Alcorn, Alcorn Law - Immigration Attorney

 

Dakota BioWorx is a pilot scale-up and bioprocessing hub in Brookings, SD. Dakota BioWorx connects innovators and researchers with fee-to-use access to bioreactors, lab space, downstream processing, and engineering support. We help transform ground-breaking ideas into sustainable, plant-based biotechnology solutions that can change the lives of millions around the world.

LEARN MORE

Brookings Economic Development Corporation is the primary engine for promoting economic growth in Brookings, South Dakota and the surrounding area. BEDC serves as an advocate for the business community by building relationships with companies that allow them to succeed by taking advantage of the area's unique and progressive business environment.

LEARN MORE

2024 PRESENTING SPONSOR
The Research Park strives to establish itself as a physical environment that can deve​lop, attract and retain technology companies that are aligned to the talent and sponsored research conducted at SDSU. ​

LEARN MORE
 

2024 GOLD SPONSOR
The University of South Dakota is a vibrant setting of innovation artistry and discovery, with research and creative activity opportunities in all disciplines across campus. USD researchers collaborate with industry professionals to bring new technologies to market as well as carrying out fundamental research in order to elucidate physical processes, improve human health, and protect the environment. In addition to individual research, the university hosts multi-disciplinary competitive research centers that foster academic excellence and spur economic growth. Biomedical engineering, chemistry, and physics are the main pillars of USD’s materials research; key research strengths and facilities within this area include the Center for Ultra-low Background Experiments in Dakotas (CUBED), Graduate Education and Applied Research Center (GEAR), and Center for Security Printing and Anti-Counterfeiting Technologies (SPACT). USD is also home to the state's only medical school. Sanford School of Medicine faculty members teach students the latest techniques and skills for a career in biomedical research. Critical biomedical research areas include anatomy and structural biology, cancer biology, immunology, cardiovascular sciences, microbiology, neuroscience, rural healthcare, pharmacology and physiology, among others. Key research groups and facilities include: South Dakota Biomedical Research Infrastructure Network (BRIN), Neuroscience & Nanotechnology Network (USD-N3), Center for Brain & Behavior Research (CBBRe) and USD’s two biomedical cores: Behavioral Core and Physiology Core.

2024 SILVER SPONSOR
Biotechnology Innovation Organization [BIO]  is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers.

LEARN MORE

South Dakota EPSCoR has partnering with South Dakota Biotech on Educator STEM grants.

The National Science Foundation (NSF) created the Established Program to Stimulate Competitive Research (EPSCoR) and South Dakota was one of the initial jurisdictions to join the program, starting in 1987. The EPSCoR program is designed to assist states to establish a self-sustaining academic research enterprise with the competitive capability that will contribute to the states' economic viability and development. SD EPSCoR's mission is to strengthen research and education in science, technology, engineering and mathematics (STEM) across South Dakota to increase science literacy and drive science-based economic development. SD EPSCoR helps build South Dakota's research infrastructure and increases its capacity to successfully compete for federal funding.

Current Goals of South Dakota EPSCoR include:

• Increase South Dakota’s science and technology research capacity

• Provide educational opportunities for K-12, undergraduate and graduate students

• Promote science-based economic development for South Dakota

LEARN MORE

2024 BRONZE SPONSOR
The USD Discovery District is an 80-acre contemporary corporate and academic research park is a public-private partnership effort between USD, the City of Sioux Falls, the South Dakota Board of Regents, the Governor’s Office of Economic Development and the business community through Forward Sioux Falls. The research park's expansion is anticipated to conclude over a 25-year timeline. Upon full completion, the expected economic outcomes encompass 26 privately constructed buildings, with a combined construction value exceeding $314 million. Additionally, the research park is projected to provide employment opportunities for nearly 2,800 individuals through companies situated within the district.

The concept for the Discovery District began more than two decades ago, with leaders in business and education coming together to set a strategy on growing technology-based business in South Dakota. In 2012, the legislature passed and Governor Daugaard signed legislation to authorize research parks on lands controlled by the South Dakota Board of Regents. The USD research park corporation was formed later that year. The USD Discovery District name was formalized in 2015. 

LEARN MORE
 

Viaflex where quality, service, and innovation meet excellence in polymer film and sheeting solutions for covers, liners, and caps. As a leader in the polymer manufacturing industry, we are dedicated to identifying the products, systems, and services best suited to tackle your containment needs. With a fully integrated system from design through installation, Viaflex is the perfect partner.

Explore Viaflex today and simplify your next containment project.

LEARN MORE

We deliver value-based breathing technologies to simplify complexity for healthcare systems, providers, and patients.

Our team has elevated ventilation design to provide ICU-standard respiratory support in an elegant and robust system that removes unnecessary complexity and cost. We aim to produce reliable solutions that are easy to use for daily and off-the-shelf ventilation so providers can focus on critical patient needs. CorVent Medical is proud to be ISO 13485 certified and compliant with 21CFR820.30 as well as cGMPs.

LEARN MORE
 

Principal connects all kinds of experts—the savvy business leader, the hardworking employee, the thoughtful investor—with the retirement, benefits, and investment insights they need to feel confident taking the next step.

For more than 140 years, we’ve helped people and businesses confidently reach their goals.

Principal has never stopped learning, growing, and adapting. Today, we continue to lead with our core values. Our culture is powered by people and led by a diverse management team. Our 19,000 employees—located in 27 nations and territories in Asia, Australia, Europe, Latin America, and North America—drive change in their own communities. Learn more about the history and impact of Principal.

LEARN MORE
 

Founded in 2004
Serving South Dakota / Iowa / Minnesota / Nebraska / North Dakota

At Risty Benefits, we realize that every company is as different as the individual employees that make up that company.  Each of our clients and prospective clients has unique needs and challenges, and we take pride in our abilities to efficiently respond to those needs and challenges.  

In a world where many companies seem to lead with pictures of their over-priced offices and their self-serving trophies, it’s important for us not to lose sight of the fact that our clients are the ones who should be receiving the most reward. 

Our team offers more than 50 years of experience servicing the states of South Dakota, North Dakota, Iowa, Minnesota, and Nebraska.  

LEARN MORE
 

VOLGA MANUFACTURING CENTER
Please join us following the Summit, to tour CBS Bio Platforms' new manufacturing center and office, just 15 miles west of Brookings.
If you'd like to attend, please respond at link below.

CBS Bio Platforms Inc. is an innovation-driven company committed to advancing feed technology and animal nutrition. With over 40 years of experience, CBS has developed a broad portfolio of natural feed supplements, enzymes, and yeast-based technologies designed to enhance animal performance, improve intestinal tract health, and support efficient disease management operations.

Our global footprint includes facilities in Canada, international markets throughout Asia and South America and now in the United States with our first production facility opening in Volga, SD. With strategic university partnerships and a robust research and development framework, CBS Bio Platforms continues to pioneer solutions that meet the evolving needs of nutritionists, veterinarians, farmers, and commercial producers.

LEARN MORE